BioLineRx Ltd Cash Flow Reinvestment Rate
BioLineRx Ltd cash flow reinvestment rate. BioLineRx Ltd (BLRX) has a Cash Flow Reinvestment Rate of 4.09x as of December 2023, reinvesting $20.41 Million (capex $18.00K plus investments $-20.39 Million) from operating cash flow of $4.99 Million. Explore BioLineRx Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of BioLineRx Ltd (2010–2010)
Cash flow reinvestment rate of BioLineRx Ltd from 2010 to 2010. Historical reinvestment intensity for BioLineRx Ltd across 1 annual periods. Explore BLRX capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
BioLineRx Ltd Cash Flow Reinvestment Rate by Year (2010–2010)
BioLineRx Ltd cash flow reinvestment rate by year from 2010 to 2010. Year-by-year capital reinvestment analysis for BioLineRx Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of BioLineRx Ltd.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2010 | 0.06x | $660.94K | $11.46 Million | $660.94K | — |